Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Most Read

  1. Lyme disease: What’s actually going on here?
  2. ImmunityBio and Microsoft create 3D model to support Covid-19 research
  3. Exscientia forms UK-US partnership to screen possible Covid-19 drugs
  4. IQVIA Q&A: do the benefits of AI outweigh ethical concerns?
  5. Tips and tricks for regulating advanced therapies

Latest Content

Contract Research Services

We recognise that the data our analytical systems give to our clients is critical for informing the development of innovative products or guaranteeing product quality is preserved during manufacture.

Development Update

Novo Nordisk announced the European Commission (EC) has granted marketing authorisation for Rybelsus®, (oral semaglutide), to treat adult patients with insufficiently controlled type 2 diabetes, improving glycemic control alongside diet and exercise.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Close
Close
Close

Go Top